Receca 10 mg/sachet Oral Powder

    Receca 10 mg/sachet

    Racecadotril

    Category: Oral Powder

    Manufacturer: NIPRO JMI Pharma Ltd.

    Price: 210.0

    30's pack

    10 mg sachet

    Uses of Receca: - Diarrhea Acute diarrhoea Hypersensitivity to Racecadotril, or to any of the excipients.
    Anti-diarrhoeal
    Racecadotril increases the availability of endogenous opioids (enkephalins) by inhibiting the membrane-bound enkephalinase. The enkephalins in turn mediate their effect through δ receptor ( delta opioid receptor) activation that induces a selective increase in Cl absorption by inhibiting adenylate cyclase.Onset: 30 min (plasma enkephalinase inhibition).
    How to use Racecadotril: Take this medicine in the dose and duration as advised by your doctor. Do not chew, crush or break it. Racecadotril is to be taken with food. Administration: May be taken with or without food. Adult Dose: Oral Acute diarrhoea Adult: 100 mg tid. Continue treatment until 2 normal stools are recorded. Max duration: 7 days. Child Dose: Oral Acute diarrhoea Child: 3 mth to 17 yr <9 kg: 10 mg tid; 9 to <13 kg: 20 mg tid; 13-27 kg: 30 mg tid; >27 kg: 60 mg tid. Continue treatment until 2 normal stools are recorded. Max duration: 7 days.
    No drug interactions found. Joint treatment with Racecadotril and Loperamide or Nifuroxazide does not modify the kinetics of Racecadotril.
    Hypersensitivity to Racecadotril, or to any of the excipients.
    Common - Vomiting - Fever Headache, tonsillitis, rash, erythema multiforme or nodosum; tongue, face, lip or eyelid oedema; angioedema, urticaria, prurigo, pruritus.
    Due to a lack of clinical data, Racecadotril should not be administered to pregnant or breastfeeding women.
    Precaution: Chronic & antibiotic-associated diarrhoea, bloddy or purulent stools & fever, patients w/ diabetes, renal or liver impairment, cases of prolonged or uncontrolled vomiting. Pregnancy, lactation.
    No cases of overdose have been reported. In adults, single doses above 2 g which is equivalent to 20 times the therapeutic dose, have been administered, and no harmful effects have been described.
    Anti-diarrhoeal
    Racecadotril increases the availability of endogenous opioids (enkephalins) by inhibiting the membrane-bound enkephalinase. These enkephalins activate delta-opioid receptors in the GI tract. This leads to a reduction in cAMP mucosal levels, resulting in a reducted secretion of water and electrolytes in the intestinal lumen.
    Due to a lack of clinical data, Racecadotril should not be administered to pregnant or breastfeeding women.
    Profile avater

    Samm Care